ASHLEY LOE: Open Payments
NPI 1568948875 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 28 payments from 10 companies in 2025. Trend: 2023 $607 · 2024 $393 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $212 |
| Amgen Inc. | 6 | $88 |
| ABBVIE INC. | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Medtronic, Inc. | 2 | $44 |
| Innovation Technologies Inc | 1 | $26 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Philips North America LLC | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: REXULTI, OTEZLA, VRAYLAR, AIRSUPRA, REPATHA, UBRELVY, IRRISEPT, LINQ II.
Industry payments across AR — which companies pay providers there.
